Abstract
Esomeprzole and naproxen are available in tablet dosage form in the ratio 1:25. Two simple, accurate, precise and economic methods; simultaneous equation method and multicomponent method have been described for the simultaneous estimation of esomeprzole and naproxen in tablet dosage form. Absorption maxima of esomeprzole and naproxen in distilled water were found to be 301.0 nm and 262.0 nm respectively. Beer’s law was obeyed in the concentration range 5-50 µg/ml for esomeprzole and 5-50 µg/ml for naproxen. The methods allow rapid analysis of binary pharmaceutical formulation with accuracy. Results of two methods were validated statistically and by recovery studies and were found to be satisfactory.
References
Budhwari S., The Merck Index, 13th Ed., Merck Research Laboratories, Whitehouse Station, New Jersey, 2001, 6913, 6443.
Sweetmann S. C. Eds., Martindale, The extra pharmacopoeia, The complete drug reference. 36th Edn., Vol. I, The Pharmaceutical Press, London, 2009, 92, 1729.
Indian Pharmacopoeia, Vol. III, Govt. India Ministry of Health and Family Welfare, The Controller of Publication, New Delhi, 2007, 1473.
British Pharmacopoeia, 4th Ed., Vol. II, Her Majesty’s Stationary Office, London, 2004, 1357.
The United State Pharmacopoeia, 31st Ed., Vol. III, United States Pharmacopoeial Convention Inc. Washington DC, 2008, 2760.
D, Moreno MA, Torrado S, Lastres JL. Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of omeprazole in aqueous solution during stability studies. J Pharm Biomed Anal. 1999;21:291–298.
Ozaltin N, Kocer A. Determination of omeprazole in pharmaceuticals by derivative spectroscopy. J Pharm Biomed Anal. 1997;16:337–342.
Dogrukol AK, Tunalier Z, Tuncel M. TLC densitometric determination of omeprazole in pharmaceutical preparations. Pharmazie. 1998;53:272–273.
Petersen KU, Schmutzler W. Proton pump inhibitors release of active substance from various preparation. Detsche Apotheker Zeitung. 1999;139:68–69.
Sluggett GW, Stong JD, Adams JH, Zhao Z. Omeprazole determination using HPLC with coulometric detection. J Pharm Biomed Anal. 2001;25:357–361.
Mathew M, Gupta VD, Bailery RE. Stability of omeprazole solutions at various pH values as determined by high performance liquid chromatography. Drug Develop Ind Pharm. 1998;21:965–971.
Ding L, Yang J, Yan HL, Zhang ZX, An DK. Determination of omeprazole and its pharmacokinetic in human plasma by an improved HPLC method. Chinese J Pharm Anal. 1999;17:458–461.
Shim SH, Bok SJ, Kwon KI. Determination of omeprazole in rat plasma by HPLC with column switching. Arch Pharm Res. 1994;17:458–461.
Zhi XJ, Hunang J, Zhang JH, Wang HT, Zhang LL. Determination of omeprazole and its metabolites in plasma by RP-HPLC. Chinese J Pharm. 1999; 30:166–168.
Motevalian M, Saeedi G, Keyhanfar F, Tayebi L, Mahmoudian M. Simultaneous determination of omeprazole and its metabolites in human plasma by HPLC using solid phase extraction. Pharm Pharmacol Commun. 1999;5:265–268.
Yeung PK, Little R, Jiang YQ, Buckley SJ, Veldhuyzen SJ, Zanten VN. Simple high performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluid. J Pharm Biomed Anal. 1998;17:1393–1398.
Kobayashi K, Chiba KO, Sohn DR, Kato Y, Ishizaki T. Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed phase high performance liquid chromatography with an alkaline resistant polymer coated C18 column. J Chromatogr B. 1992;117:299–305.
Amantea MA, Narang PK. Improved procedure for quantization of omeprazole and metabolites using reversed phase high performance liquid chromatography. J Chromatogr A. 1988;426:216–222.
Hassan-Alin M, Andersson T, Bredberg E, Rohss K. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur J Clin Pharmacol. 2000;56-1:665–670.
Johnson DA, Roach AC, Carlsson AS, Karlsson AA, Behr DE. Stability of esomeprazole capsule contents after in vitro suspension in common soft foods and beverages. Pharmacotherapy. 2003;23:731–734.
Harry GB. Analytical profiles of drug substances and excipients. Vol. 21. Elsevier, a division of Reed Elsevier India Pvt. Ltd., 2005; 345-373.
Toshi H., Shozo M., Ikea K. Simultaneous analysis of naproxen in human urine by high-performance liquid chromatography with normal solid-phase extraction. J Chromatogr. B: Biomed Sci Appl. 1997; 692 (2, 9): 375-388.
Lotfi M., Frida D. Simultaneous determination of naproxen and related compounds by HPLC using porous graphitic carbon column. J Pharm Biomed Anal. 2003; 32(4): 1087-1092.
Mouiay H., Nadia A., Hocine C. Assay of Naproxen in Rat Serum by High- Performance Thin-Layer Chromatography. J Association of Analytical Chemists International. 2000; 83(6): 1489-1492.
Chan C. C. Analytical Method Validation and Instrument Performance Verification, Wiley Interscience. 2004, 16-22.
Validation of analytical procedure: methodology Q2B, ICH Harmonized Tripartite Guidelines, 1996, 1-8.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array